Access Bio, Inc. is a New Jersey based corporation specialized in the development, manufacture, and marketing of IVD tests under CareStart™. The company utilizes advanced lateral flow technology and its CareStart™ malaria RDTs have been recognized as one of the world's leading brands due to their excellent quality. Access Bio, Inc. has recently expanded its impressive RDT portfolio to include Influenza A & B, Strep A, G6PD, and COVID-19.